首页> 美国卫生研究院文献>Gastroenterology Research and Practice >Effect of Non-Anticoagulant N-Desulfated Heparin on Basic Fibroblast Growth Factor Expression Angiogenesis and Metastasis of Gastric Carcinoma In Vitro and In Vivo
【2h】

Effect of Non-Anticoagulant N-Desulfated Heparin on Basic Fibroblast Growth Factor Expression Angiogenesis and Metastasis of Gastric Carcinoma In Vitro and In Vivo

机译:非抗凝N-脱硫肝素对胃癌体内和体外碱性成纤维细胞生长因子表达血管生成和转移的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective. The present study was performed to investigate the effect of N-desulfated heparin on basic fibroblast growth factor (bFGF) expression, tumor angiogenesis and metastasis of gastric carcinoma. Methods. Human gastric cancer SGC-7901 tissues were orthotopically implanted into the stomach of NOD SCID mice. Twenty mice were randomly divided into two groups which received either intravenous injection of 0.9% NaCl solution (normal saline group) or 10 mg/kg N-desulfated heparin (N-desulfated heparin group) twice weekly for three weeks. In vitro, human gastric carcinoma SGC-7901 cells were treated with N-desulfated heparin in different concentration (0.1 mg/mL, 1 mg/mL, N-desulfated heparin group), and treated with medium (control group). Results. In vivo, the tumor metastasis rates were 9/10 in normal saline group and 2/10 in N-desulfated heparin group (P < 0.05). The intratumoral microvessel density was higher in normal saline group than in N-desulfated heparin group (P < 0.05). bFGF expression in gastric tissue was inhibited by N-desulfated heparin (P < 0.05). There was no bleeding in N-desulfated heparin group. In vitro, N-desulfated heparin inhibited significantly bFGF protein and mRNA expression of gastric carcinoma cells (P < 0.05). Conclusions. N-desulfated heparin can inhibit the metastasis of gastric cancer through inhibiting tumor bFGF expression and tumor angiogenesis with no obvious anticoagulant activity.
机译:目的。本研究旨在探讨N-脱硫肝素对胃癌碱性成纤维细胞生长因子(bFGF)表达,肿瘤血管生成和转移的影响。方法。将人胃癌SGC-7901组织原位植入NOD SCID小鼠的胃中。将20只小鼠随机分为两组,每星期两次,分别静脉注射0.9%NaCl溶液(生理盐水组)或10μmg/ kg N-脱硫肝素(N-脱硫肝素组)。在体外,将人胃癌SGC-7901细胞用不同浓度的N-脱硫肝素(0.1μg/ mL,1μmg/ mL,N-脱硫肝素组)处理,并用培养基处理(对照组)。结果。在体内,生理盐水组的肿瘤转移率为9/10,而N-脱硫肝素组的肿瘤转移率为2/10(P <0.05)。生理盐水组的肿瘤内微血管密度高于N-脱硫肝素组(P <0.05)。 N-脱硫肝素可抑制胃组织中bFGF的表达(P <0.05)。 N-脱硫肝素组无出血。在体外,N-脱硫肝素可显着抑制胃癌细胞的bFGF蛋白和mRNA表达(P <0.05)。结论。 N-脱硫肝素可通过抑制肿瘤bFGF的表达和肿瘤血管生成而抑制胃癌的转移,无明显的抗凝活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号